Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Economic Recession | 11 | 2023 | 78 | 4.150 |
Why?
|
| Uncertainty | 7 | 2023 | 734 | 1.900 |
Why?
|
| Accidents, Traffic | 6 | 2023 | 819 | 1.580 |
Why?
|
| Unemployment | 5 | 2023 | 214 | 1.560 |
Why?
|
| Suicide | 4 | 2022 | 1477 | 1.130 |
Why?
|
| Automobile Driving | 2 | 2023 | 431 | 1.050 |
Why?
|
| Health Care Reform | 4 | 2017 | 1261 | 1.030 |
Why?
|
| Economics | 2 | 2018 | 146 | 1.020 |
Why?
|
| Drug Industry | 7 | 2014 | 746 | 1.010 |
Why?
|
| Commerce | 2 | 2022 | 592 | 0.840 |
Why?
|
| Greece | 6 | 2021 | 344 | 0.730 |
Why?
|
| Alcoholic Beverages | 1 | 2022 | 265 | 0.730 |
Why?
|
| England | 4 | 2023 | 522 | 0.660 |
Why?
|
| Agriculture | 1 | 2019 | 190 | 0.630 |
Why?
|
| Democracy | 1 | 2017 | 28 | 0.610 |
Why?
|
| Wounds and Injuries | 2 | 2021 | 2400 | 0.600 |
Why?
|
| General Practice | 1 | 2018 | 100 | 0.600 |
Why?
|
| Health Care Sector | 1 | 2017 | 194 | 0.540 |
Why?
|
| Cardiovascular System | 1 | 2023 | 832 | 0.520 |
Why?
|
| Culture | 1 | 2019 | 633 | 0.520 |
Why?
|
| Motor Vehicles | 3 | 2022 | 268 | 0.510 |
Why?
|
| Drug and Narcotic Control | 1 | 2015 | 146 | 0.470 |
Why?
|
| Financing, Government | 2 | 2013 | 468 | 0.430 |
Why?
|
| Mortality | 2 | 2023 | 2864 | 0.430 |
Why?
|
| Drug Costs | 4 | 2013 | 1105 | 0.420 |
Why?
|
| Morbidity | 1 | 2017 | 1769 | 0.410 |
Why?
|
| Risk-Taking | 1 | 2017 | 986 | 0.410 |
Why?
|
| Hospitals, Public | 1 | 2013 | 207 | 0.410 |
Why?
|
| Diagnosis-Related Groups | 1 | 2013 | 455 | 0.400 |
Why?
|
| Biomedical Technology | 1 | 2013 | 220 | 0.380 |
Why?
|
| Drug Substitution | 1 | 2013 | 281 | 0.370 |
Why?
|
| Wales | 2 | 2020 | 85 | 0.350 |
Why?
|
| Health | 1 | 2013 | 394 | 0.350 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 1637 | 0.340 |
Why?
|
| Police | 2 | 2022 | 149 | 0.330 |
Why?
|
| Health Behavior | 2 | 2017 | 2636 | 0.320 |
Why?
|
| Drugs, Generic | 1 | 2013 | 421 | 0.320 |
Why?
|
| Proton Pump Inhibitors | 1 | 2013 | 526 | 0.310 |
Why?
|
| Health Policy | 4 | 2014 | 2661 | 0.300 |
Why?
|
| Costs and Cost Analysis | 3 | 2022 | 1681 | 0.300 |
Why?
|
| Reimbursement Mechanisms | 1 | 2013 | 670 | 0.300 |
Why?
|
| Health Status | 2 | 2017 | 4034 | 0.290 |
Why?
|
| Cyprus | 2 | 2017 | 79 | 0.290 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 1518 | 0.280 |
Why?
|
| Internationality | 1 | 2011 | 1003 | 0.260 |
Why?
|
| Guideline Adherence | 2 | 2015 | 2266 | 0.260 |
Why?
|
| Prescription Drugs | 2 | 2013 | 595 | 0.260 |
Why?
|
| Communicable Disease Control | 2 | 2021 | 857 | 0.250 |
Why?
|
| Pandemics | 2 | 2021 | 8388 | 0.230 |
Why?
|
| Economics, Pharmaceutical | 2 | 2015 | 87 | 0.220 |
Why?
|
| Stress, Psychological | 1 | 2018 | 4245 | 0.210 |
Why?
|
| Scotland | 1 | 2022 | 155 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
| Health Expenditures | 5 | 2017 | 2348 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
| Models, Econometric | 1 | 2021 | 218 | 0.190 |
Why?
|
| Delivery of Health Care | 2 | 2017 | 5319 | 0.190 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 15165 | 0.190 |
Why?
|
| Efficiency, Organizational | 2 | 2017 | 695 | 0.180 |
Why?
|
| Alcohol Drinking | 2 | 2023 | 3966 | 0.180 |
Why?
|
| Humans | 28 | 2023 | 744343 | 0.170 |
Why?
|
| Holidays | 1 | 2019 | 42 | 0.170 |
Why?
|
| Florida | 1 | 2020 | 435 | 0.170 |
Why?
|
| Depression | 1 | 2018 | 7766 | 0.170 |
Why?
|
| Congo | 1 | 2017 | 13 | 0.160 |
Why?
|
| European Union | 1 | 2018 | 158 | 0.160 |
Why?
|
| Health Care Costs | 1 | 2011 | 3209 | 0.150 |
Why?
|
| Drug Utilization Review | 1 | 2018 | 245 | 0.150 |
Why?
|
| Obesity | 1 | 2019 | 12745 | 0.150 |
Why?
|
| Federal Government | 1 | 2017 | 260 | 0.140 |
Why?
|
| United States | 8 | 2023 | 69872 | 0.120 |
Why?
|
| Choice Behavior | 1 | 2019 | 803 | 0.110 |
Why?
|
| Poland | 1 | 2013 | 184 | 0.110 |
Why?
|
| Cannabis | 1 | 2019 | 439 | 0.110 |
Why?
|
| Bayes Theorem | 1 | 2020 | 2309 | 0.110 |
Why?
|
| Patents as Topic | 1 | 2013 | 103 | 0.100 |
Why?
|
| Sex Factors | 2 | 2018 | 10397 | 0.100 |
Why?
|
| Marketing of Health Services | 1 | 2012 | 153 | 0.100 |
Why?
|
| Emotions | 1 | 2023 | 2661 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2018 | 1162 | 0.090 |
Why?
|
| Cost Control | 1 | 2012 | 624 | 0.090 |
Why?
|
| Europe | 2 | 2013 | 3339 | 0.090 |
Why?
|
| Policy | 1 | 2013 | 508 | 0.080 |
Why?
|
| Health Surveys | 1 | 2017 | 4037 | 0.080 |
Why?
|
| Attention | 1 | 2018 | 2400 | 0.070 |
Why?
|
| Time Factors | 2 | 2019 | 40075 | 0.070 |
Why?
|
| Risk Factors | 3 | 2019 | 72290 | 0.070 |
Why?
|
| Models, Economic | 1 | 2011 | 713 | 0.070 |
Why?
|
| National Health Programs | 1 | 2010 | 445 | 0.070 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 2838 | 0.070 |
Why?
|
| Drug Approval | 1 | 2012 | 742 | 0.070 |
Why?
|
| Male | 6 | 2021 | 350118 | 0.060 |
Why?
|
| Developing Countries | 1 | 2017 | 2815 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3508 | 0.060 |
Why?
|
| Mental Health | 1 | 2018 | 3019 | 0.060 |
Why?
|
| Female | 6 | 2021 | 380194 | 0.060 |
Why?
|
| Drug Discovery | 1 | 2012 | 1058 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 3674 | 0.060 |
Why?
|
| Pharmaceutical Preparations | 1 | 2012 | 1071 | 0.060 |
Why?
|
| Exercise | 1 | 2019 | 5615 | 0.050 |
Why?
|
| Insurance, Health | 1 | 2015 | 2494 | 0.050 |
Why?
|
| Self Report | 1 | 2013 | 3558 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2013 | 3589 | 0.050 |
Why?
|
| Diet | 1 | 2019 | 7939 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2011 | 1797 | 0.040 |
Why?
|
| Homicide | 1 | 2022 | 287 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 214055 | 0.040 |
Why?
|
| Ireland | 1 | 2014 | 161 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 5137 | 0.030 |
Why?
|
| Young Adult | 2 | 2017 | 56430 | 0.030 |
Why?
|
| Russia | 1 | 2014 | 408 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2013 | 6600 | 0.030 |
Why?
|
| Suicidal Ideation | 1 | 2022 | 1248 | 0.030 |
Why?
|
| Switzerland | 1 | 2013 | 255 | 0.030 |
Why?
|
| Adolescent | 2 | 2017 | 85781 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2013 | 23338 | 0.030 |
Why?
|
| France | 1 | 2013 | 517 | 0.030 |
Why?
|
| Germany | 1 | 2013 | 862 | 0.020 |
Why?
|
| Legislation, Drug | 1 | 2012 | 206 | 0.020 |
Why?
|
| Australia | 1 | 2013 | 1170 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 7785 | 0.020 |
Why?
|
| Financing, Personal | 1 | 2010 | 308 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 2065 | 0.020 |
Why?
|
| Middle Aged | 2 | 2017 | 213383 | 0.020 |
Why?
|
| Brazil | 1 | 2010 | 1270 | 0.020 |
Why?
|
| Family Characteristics | 1 | 2010 | 1000 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2012 | 1584 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2013 | 77449 | 0.010 |
Why?
|
| Income | 1 | 2010 | 1913 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 3610 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 25043 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 63114 | 0.000 |
Why?
|
| Aged | 1 | 2014 | 163280 | 0.000 |
Why?
|
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_